首页> 外文期刊>The Journal of dermatological treatment >Primary frontal hyperhidrosis successfully treated with low doses of botulinum toxin A as a useful alternative to surgical treatment
【24h】

Primary frontal hyperhidrosis successfully treated with low doses of botulinum toxin A as a useful alternative to surgical treatment

机译:低剂量肉毒杆菌毒素A成功治疗了原发性额叶多汗症,是手术治疗的有效替代方法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Frontal hyperhidrosis appears to be a special and rare form of focal hyperhidrosis. These patients may suffer greatly from the condition so an efficient treatment is highly demanded. Surgical treatment may solve this problem permanently, but the possibility of serious complications and low satisfactory results makes it less advisable than in other types of hyperhidrosis where surgery has shown great benefits. We report a case of primary frontal hyperhidrosis in a young man who refused surgery and was treated with low doses of botulinum toxin type A injected into the forehead. The patient noted a high level of satisfaction, with the abolishment of sweating and a long effect that was maintained for up to 10 months without any complications. In conclusion, we consider that low doses of botulinum toxin A is a well tolerated, safe and very effective treatment for primary frontal hyperhidrosis and it should be offered as an alternative to patients who suffer from this disorder.
机译:额叶多汗症是局灶性多汗症的一种特殊且罕见的形式。这些患者可能患有这种疾病,因此迫切需要有效的治疗方法。手术治疗可能会永久性地解决该问题,但是严重并发症的可能性和较低的令人满意的结果使其比其他类型的多汗症的手术效果显着,因此不建议这样做。我们报告了一名年轻人的原发性多汗症,该人拒绝手术,并接受了低剂量的A型肉毒杆菌毒素治疗。病人表现出很高的满意度,可以避免流汗,并且可以保持长达10个月的无任何并发症的长期效果。总之,我们认为低剂量的肉毒杆菌毒素A对于原发性额叶多汗症是一种耐受良好,安全且非常有效的治疗方法,应该作为患有这种疾病的患者的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号